← Back to Search

Avatar-based Mobile Phone Intervention for Medication Adherence and Retention in Care

N/A

Recruiting

Led By Mark Dworkin, MD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months before enrollment through two months after study conclusion (15 months).

Awards & highlights

Study Summary

This trial will test whether a mobile phone app featuring a talking Avatar can help improve HIV care adherence and retention rates among African American men who have sex with men.

Eligible Conditions

Retention in Care
Medication Adherence

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months before enrollment through two months after study conclusion (15 months).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months before enrollment through two months after study conclusion (15 months).

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months before enrollment through two months after study conclusion (15 months). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Viral suppression

Secondary outcome measures

Antiretroviral therapy adherence

Retention in care

Trial Design

2Treatment groups

Experimental Treatment

Group I: Control appExperimental Treatment1 Intervention

The control app is a mobile phone app that features a realistic talking human avatar who primarily promotes food safety and also offers knowledge of sugar content in food. This app is expected to have no effect on ART adherence and retention in care, however, it has never been tested to determine if it may have any effect so it has been categorized as Other (arm type) rather than as placebo.

Group II: Avatar intervention appExperimental Treatment1 Intervention

The intervention is a mobile phone app that features a realistic talking human avatar who promotes adherence to ART and retention in care, motivates, and provides information and opportunities for HIV care-related behavioral skills.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

607 Previous Clinical Trials

1,559,060 Total Patients Enrolled

Ruth M. Rothstein CORE CenterOTHER

10 Previous Clinical Trials

2,521 Total Patients Enrolled

Emory UniversityOTHER

1,636 Previous Clinical Trials

2,560,278 Total Patients Enrolled

Media Library

My Personal Health Guide Clinical Trial Eligibility Overview. Trial Name: NCT04217174 — N/A

Retention in Care Clinical Trial 2023: My Personal Health Guide Highlights & Side Effects. Trial Name: NCT04217174 — N/A

My Personal Health Guide 2023 Treatment Timeline for Medical Study. Trial Name: NCT04217174 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for trial participants?

"According to clinicaltrials.gov, the recruitment process for this medical trial has yet to be completed. This research endeavour was posted on March 4th 2020 and subsequently updated December 1st 2022."

Answered by AI

Is elderly recruitment being pursued for this trial?

"Candidates aged between 18 and 34 are eligible for this trial. Alternatively, there are 20 trials available to minors and 69 tailored towards people over 65 years old."

Answered by AI

What criteria must an individual meet to be eligible for participating in this trial?

"To be admitted to this clinical trial, candidates must exhibit a commitment to staying engaged in care and have the proper age requirement (18-34). A total of 295 subjects are needed for the medical research."

Answered by AI

Recent research and studies

AIDS Education and PreventionJournal

Acceptability, Feasibility, and Preliminary Efficacy of a Theory-based Relational Embodied Conversational Agent Mobile Phone Intervention to Promote HIV Medication Adherence in Young Hiv-positive African American MSM

Dworkin, Mark S., Sangyoon Lee, Apurba Chakraborty, Colleen Monahan, Lisa Hightow-Weidman, Robert Garofalo, Dima M. Qato, Li Liu, and Antonio Jimenez. 2019. “Acceptability, Feasibility, and Preliminary Efficacy of a Theory-based Relational Embodied Conversational Agent Mobile Phone Intervention to Promote HIV Medication Adherence in Young Hiv-positive African American MSM”. AIDS Education and Prevention. Guilford Publications. doi:10.1521/aeap.2019.31.1.17.

JMIR mHealth and uHealthJournal

A Realistic Talking Human Embodied Agent Mobile Phone Intervention to Promote HIV Medication Adherence and Retention in Care in Young Hiv-positive African American Men Who Have Sex with Men: Qualitative Study

Dworkin, Mark, Apurba Chakraborty, Sangyoon Lee, Colleen Monahan, Lisa Hightow-Weidman, Robert Garofalo, Dima Qato, and Antonio Jimenez. 2018. “A Realistic Talking Human Embodied Agent Mobile Phone Intervention to Promote HIV Medication Adherence and Retention in Care in Young Hiv-positive African American Men Who Have Sex with Men: Qualitative Study”. JMIR Mhealth and Uhealth. JMIR Publications Inc.. doi:10.2196/10211.

clinicaltrials.govStudy

An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM

Mark S Dworkin 2020. "An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04217174.